3,637
Views
11
CrossRef citations to date
0
Altmetric
Coronavirus – Research Paper

Factors associated with COVID-19 vaccine hesitancy in Senegal: A mixed study

ORCID Icon, , , , , , ORCID Icon & ORCID Icon show all
Article: 2060020 | Received 21 Dec 2021, Accepted 27 Mar 2022, Published online: 11 May 2022

References

  • Rutten LJF, Zhu X, Leppin AL, Ridgeway JL, Swift MD, Griffin JM, St Sauver JL, Virk A, Jacobson RM. Evidence-based strategies for clinical organizations to address COVID-19 vaccine hesitancy. Mayo Clin Proc. 2021;96(3):699. doi:10.1016/J.MAYOCP.2020.12.024.
  • Kabamba Nzaji M, Kabamba Ngombe L, Ngoie Mwamba G, Banza Ndala DB, Mbidi Miema J, Luhata Lungoyo C, Lora Mwimba B, Cikomola Mwana Bene A, Mukamba Musenga E. Acceptability of vaccination against COVID-19 among healthcare workers in the Democratic Republic of the Congo. Pragmatic Obs Res. 2020;11:103–12. doi:10.2147/por.s271096.
  • Al-Jayyousi GF, Sherbash MAM, Ali LAM, El-Heneidy A, Alhussaini NWZ, Elhassan MEA, Nazzal MA. Factors influencing public attitudes towards COVID-19 vaccination: a scoping review informed by the socio-ecological model. Vaccines. 2021;9(6):548. doi:10.3390/VACCINES9060548.
  • Soares P, Rocha JV, Moniz M, Gama A, Laires PA, Pedro AR, Dias S, Leite A, Nunes C. Factors associated with COVID-19 vaccine hesitancy. Vaccines. 2021;9(3):300. doi:10.3390/VACCINES9030300.
  • Vignaud L-H. Review of vaccinations. Le mythe du refus par Laurence Monnais. Can Bull Med Hist. 2020;37(1):313–16. doi:10.3138/cbmh.398-102019.
  • MacDonald N; SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–64. doi:10.1016/J.VACCINE.2015.04.036.
  • Chen M, Li Y, Chen J, Wen Z, Feng F, Zou H, Fu C, Chen L, Shu Y, Sun C, et al. An online survey of the attitude and willingness of Chinese adults to receive COVID-19 vaccination. Hum Vaccin Immunother. 2021;17(7):2279–88. doi:10.1080/21645515.2020.1853449.
  • Nguyen KH, Srivastav A, Razzaghi H, Williams W, Lindley MC, Jorgensen C, Abad N, Singleton JA. COVID-19 vaccination intent, perceptions, and reasons for not vaccinating among groups prioritized for early vaccination — United States, September and December 2020. Morb Mortal Wkly Rep. 2021;70(6):217. doi:10.15585/MMWR.MM7006E3.
  • Williams L, Gallant AJ, Rasmussen S, Brown Nicholls LA, Cogan N, Deakin K, Young D, Flowers P. Towards intervention development to increase the uptake of COVID-19 vaccination among those at high risk: outlining evidence-based and theoretically informed future intervention content. Br J Health Psychol. 2020;25(4):1039–54. doi:10.1111/BJHP.12468.
  • Lin Y, Hu Z, Zhao Q, Alias H, Danaee M, Wong LP. Understanding COVID-19 vaccine demand and hesitancy: a nationwide online survey in China. PLoS Negl Trop Dis. 2020;14(12):e0008961. doi:10.1371/JOURNAL.PNTD.0008961.
  • Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, Setiawan AM, Rajamoorthy Y, Sofyan H, Mudatsir M, et al. Acceptance of a COVID-19 vaccine in Southeast Asia: a cross-sectional study in Indonesia. Front Public Heal. 2020;8:381. doi:10.3389/FPUBH.2020.00381.
  • Bell S, Clarke R, Mounier-Jack S, Walker JL, Paterson P. Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: a multi-methods study in England. Vaccine. 2020;38(49):7789. doi:10.1016/J.VACCINE.2020.10.027.
  • Sallam M, Dababseh D, Eid H, Al-Mahzoum K, Al-Haidar A, Taim D, Yaseen A, Ababneh NA, Bakri FG, Mahafzah A, et al. High rates of COVID-19 vaccine hesitancy and its association with bonspiracy beliefs: a study in Jordan and Kuwait among other Arab countries. Vaccines. 2021;9(1):1–16. doi:10.3390/VACCINES9010042.
  • Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines. 2021;9(2):1–15. doi:10.3390/VACCINES9020160.
  • Ekwebelem OC, Yunusa I, Onyeaka H, Ekwebelem NC, Nnorom-Dike O. COVID-19 vaccine rollout: will it affect the rates of vaccine hesitancy in Africa? Public Health. 2021;197:e18–e19. doi:10.1016/J.PUHE.2021.01.010.
  • Robinson E, Jones A, Lesser I, Daly M. International estimates of intended uptake and refusal of COVID-19 vaccines: a rapid systematic review and meta-analysis of large nationally representative samples. Vaccine. 2021;39(15):2024. doi:10.1016/J.VACCINE.2021.02.005.
  • Troiano G, Nardi A. Vaccine hesitancy in the era of COVID-19. Public Health. 2021;194:245–51. doi:10.1016/j.puhe.2021.02.025.
  • Ministère de la Santé et de l’action Sociale. Stratégie Nationale de La Vaccination Contre La COVID-19; 2021.
  • Centre des Opérations d’Urgence Sanitaire/Ministère de la Santé et de l’action Sociale. Riposte à La Pandémie de COVID-19 Au Sénégal Rapport de Situation No 121 Du 15 Novembre 2021; 2021.
  • Ministère de la Santé et de l’action Sociale. Communiqué 703 du 02 Février 2022. [accessed 2022 Feb 2]. https://www.sante.gouv.sn/sites/default/files/COMMUNIQUE%20703%20du%2002%2002%202022.pdf .
  • De Allegri M, Sieleunou I, Abiiro GA, Ridde V. How far is mixed methods research in the field of health policy and systems in Africa? a scoping review. Health Policy Plan. 2018;33(3):445–55. doi:10.1093/heapol/czx182.
  • Hong Q, Pluye P, Fàbregues S, et al. Mixed methods appraisal tool (MMAT), Version 2018. User guide. McGill. Published online 2018:1–11. http://mixedmethodsappraisaltoolpublic.pbworks.com/w/file/fetch/127916259/MMAT_2018_criteria-manual_2018-08-01_ENG.pdf%0Ahttp://mixedmethodsappraisaltoolpublic.pbworks.com/ .
  • Ridde V, Kane B, Gaye I, et al. Acceptability of government measures against Covid-19 pandemic in Senegal: a mixed methods study. Researchsquare. doi:10.21203/rs.3.rs-131071/v1.
  • Deville J-C. Une théorie des enquêtes par quotas. Tech D’Enquête, Stat Canada. 1991;12:177–95.
  • Ridde V, Ba MF, Gaye I, Diallo AI, Bonnet E, Faye A. Participating in a vaccine trial for COVID-19 in Senegal: trust and information. Hum Vaccin Immunother. 2021;17(11):3907–12. doi:10.1080/21645515.2021.1951097.
  • Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York (USA): Wiley-Interscience Publication; 2000.
  • Zhang Z. Model building strategy for logistic regression: purposeful selection. Ann Transl Med. 2016;4(6):4–10. doi:10.21037/atm.2016.02.15.
  • Miles MB, Huberman AM. Qualitative data analysis: An expanded sourcebook 2nd; 1994. New York: Sage .
  • Huijts NMA, Molin EJE, Steg L. Psychological factors influencing sustainable energy technology acceptance: a review-based comprehensive framework. Renew Sustain Energy Rev. 2012;16(1):525–31. doi:10.1016/j.rser.2011.08.018.
  • Pluye P, Grad RM, Levine A, Nicolau B. Understanding divergence of quantitative and qualitative data (or results) in mixed methods studies. Int J Mult Res Appr. 2009;3(1):58–72. doi:10.5172/mra.455.3.1.58.
  • Grossman VA. The COVID-19 vaccine: why the hesitancy? J Radiol Nurs. 2021;40(2):116. doi:10.1016/J.JRADNU.2021.02.011.
  • Prickett KC, Habibi H, Carr PA. COVID-19 vaccine hesitancy and acceptance in a Cohort of diverse New Zealanders. Lancet Reg Heal – West Pacific. 2021;14:100241. doi:10.1016/J.LANWPC.2021.100241.
  • Sherman SM, Smith LE, Sim J, Amlôt R, Cutts M, Dasch H, Rubin GJ, Sevdalis N. COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVaccs), a nationally representative cross-sectional survey. Hum Vaccin Immunother. 2021;17(6):1612. doi:10.1080/21645515.2020.1846397.
  • Khubchandani J, Sharma S, Price JH, Wiblishauser MJ, Sharma M, Webb FJ. COVID-19 vaccination hesitancy in the United States: a rapid national Aasessment. J Community Health. 2021;46(2):270–77. doi:10.1007/s10900-020-00958-x.
  • Ba MF, Ridde V, Diallo AI, et al. Acceptability of contact management and care of simple cases of COVID-19 at home: a mixed-method study in Senegal. medRxiv. doi:10.1101/2021.03.10.21253266.
  • Iliyasu Z, Umar AA, Abdullahi HM, Kwaku AA, Amole TG, Tsiga-Ahmed FI, Garba RM, Salihu HM, Aliyu MH. “They have produced a vaccine, but we doubt if COVID-19 exists” : correlates of COVID-19 vaccine acceptability among adults in Kano, Nigeria. Hum Vaccines Immunother. 2021;17(11):4057–64. doi:10.1080/21645515.2021.1974796.
  • Assefa Y, Gilks CF, Reid S, van de Pas R, Gete DG, Van Damme W. Analysis of the COVID-19 pandemic: lessons towards a more effective response to public health emergencies. Global Health. 2022;18(1):1–13. doi:10.1186/s12992-022-00805-9.
  • Marzo RR, Ahmad A, Islam S, Essar MY, Heidler P, King I, Thiyagarajan A, Jermsittiparsert K, Songwathana K, Younus DA, et al. Perceived COVID-19 vaccine effectiveness, acceptance, and drivers of vaccination decision-making among the general adult population : a global survey of 20 countries. PLoS Negl Trop Dis. 2022;16(1):1–16. doi:10.1371/journal.pntd.0010103.
  • Simas C, Larson HJ. Overcoming vaccine hesitancy in low-income and middle-income regions. Nat Rev Dis Prim. 2021;7(1):1–2. doi:10.1038/s41572-021-00279-w.
  • Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, Zigron A, Srouji S, Sela E. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020;35(8):775–79. doi:10.1007/S10654-020-00671-Y.
  • Alabdulla M, Reagu SM, Al-Khal A, Elzain M, Jones RM. COVID-19 vaccine hesitancy and attitudes in Qatar: a national cross-sectional survey of a migrant-majority population. Influenza Other Respi Viruses. 2021;15(3):361–70. doi:10.1111/irv.12847.
  • Galbadage T, Peterson BM, Awada J, Buck AS, Ramirez DA, Wilson J, Gunasekera RS. Systematic review and meta-analysis of sex-specific COVID-19 clinical outcomes. Front Med. 2020;7:348. doi:10.3389/FMED.2020.00348.
  • Okubo R, Yoshioka T, Ohfuji S, Matsuo T, Tabuchi T. COVID-19 vaccine hesitancy and its associated factors in Japan. Vaccines. 2021;9(6):662. doi:10.3390/VACCINES9060662.
  • COVID-19 infodemic trends in the African region. 2021. WHO AFRO: Africa Infodemic Response Alliance
  • Badur S, Ota M, Öztürk S, Adegbola R, Dutta A. Vaccine confidence: the keys to restoring trust. Hum Vaccin Immunother. 2020;16(5):1007. doi:10.1080/21645515.2020.1740559.
  • McAteer J, Yildirim I, Chahroudi A. The VACCINES act: deciphering vaccine hesitancy in the time of COVID-19. Clin Infect Dis an off Publ Infect Dis Soc Am. 2020;71(15):703. doi:10.1093/CID/CIAA433.
  • Lazarus JV, Ratzan SC, Palayew A, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):1. doi:10.1038/S41591-020-1124-9.
  • Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll MD, Fang H. Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China. Vaccines. 2020;8(3):1–14. doi:10.3390/VACCINES8030482.
  • Seale H, Heywood AE, Leask J, Sheel M, Durrheim DN, Bolsewicz K, Kaur R. Examining Australian public perceptions and behaviors towards a future COVID-19 vaccine. BMC Infect Dis. 2021;21(1):120. doi:10.1186/S12879-021-05833-1.
  • Popa GL, Muntean A-A, Muntean M-M, Popa MI. Knowledge and attitudes on vaccination in Southern Romanians: a cross-sectional questionnaire. Vaccines. 2020;8(4):1–7. doi:10.3390/VACCINES8040774.
  • Alley SJ, Stanton R, Browne M, To QG, Khalesi S, Williams SL, Thwaite TL, Fenning AS, Vandelanotte C. As the pandemic progresses, how does willingness to vaccinate against COVID-19 evolve? Int J Environ Res Public Health. 2021;18(2):1–14. doi:10.3390/IJERPH18020797.
  • Reiter PL, Pennell ML, Katz ML. Acceptability of a COVID-19 vaccine among adults in the United States: how many people would get vaccinated? Vaccine. 2020;38(42):6500. doi:10.1016/J.VACCINE.2020.08.043.
  • Feleszko W, Lewulis P, Czarnecki A, Waszkiewicz P. Flattening the Curve of COVID-19 Vaccine Rejection—An International Overview. Vaccines. 2021;9(1):1–8. doi:10.3390/VACCINES9010044.
  • Puri N, Coomes EA, Haghbayan H, Gunaratne K. Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases. Hum Vaccin Immunother. 2020;16(11):2586. doi:10.1080/21645515.2020.1780846.
  • Boogart LM, Ojikutu BO, Tyagi K, Klein DJ, Mutchler MG, Dong L, Lawrence SJ, Thomas DR, Kellman S. COVID-19 related medical mistrust, health impacts, and potential vaccine hesitancy among Black Americans living with HIV. J Acquir Immune Defic Syndr. 2021;86(2):200. doi:10.1097/QAI.0000000000002570.